340 related articles for article (PubMed ID: 3276038)
41. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion.
Kitade H; Kawai M; Rutgeerts O; Landuyt W; Waer M; Mathieu C; Pirenne J
J Immunol; 2005 Oct; 175(8):4963-70. PubMed ID: 16210598
[TBL] [Abstract][Full Text] [Related]
42. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
[TBL] [Abstract][Full Text] [Related]
43. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
Yamaguchi Y; Mori K; Bollinger RR
J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
[TBL] [Abstract][Full Text] [Related]
44. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
Wood KJ; Hopley A; Dallman MJ; Morris PJ
Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
[TBL] [Abstract][Full Text] [Related]
45. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants.
Siemionow M; Demir Y; Mukherjee A; Klimczak A
Transplantation; 2005 Mar; 79(5):558-67. PubMed ID: 15753845
[TBL] [Abstract][Full Text] [Related]
46. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
Yang CP; Shittu E; McManus B; Wood PJ; Bell EB
Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346
[TBL] [Abstract][Full Text] [Related]
47. Morphologic studies of acute rat cardiac allograft rejection across an isolated major histocompatibility complex class I (RT1A) disparity.
Forbes RD; Lowry RP; Darden AG; Gomersall M; Marghesco DM
Transplantation; 1988 May; 45(5):943-8. PubMed ID: 3285541
[TBL] [Abstract][Full Text] [Related]
48. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
[TBL] [Abstract][Full Text] [Related]
50. Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts.
Treseler PA; Sanfilippo F
Transplantation; 1986 Apr; 41(4):508-14. PubMed ID: 3515652
[TBL] [Abstract][Full Text] [Related]
51. Contributions of donor and host blood vessels in CNS allografts.
Baker-Cairns BJ; Sloan DJ; Broadwell RD; Puklavec M; Charlton HM
Exp Neurol; 1996 Nov; 142(1):36-46. PubMed ID: 8912897
[TBL] [Abstract][Full Text] [Related]
52. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
53. Immune mechanisms in organ allograft rejection. VI. Delayed-type hypersensitivity and lymphotoxin in experimental renal allograft rejection.
Lowry RP; Marghesco DM; Blackburn JH
Transplantation; 1985 Aug; 40(2):183-8. PubMed ID: 3895626
[TBL] [Abstract][Full Text] [Related]
54. Humoral immunity to heterotopic corneal allografts in the rat.
Treseler PA; Sanfilippo F
Transplantation; 1985 Feb; 39(2):193-6. PubMed ID: 3881856
[TBL] [Abstract][Full Text] [Related]
55. Posttransplant infusion of donor-specific blood induces immunological unresponsiveness in rat hepatic allografts.
Liang J; Yamaguchi Y; Matsuda T; Ohshiro H; Zhang JL; Okabe K; Matsumura F; Ishihara K; Uchino S; Mori K; Yamada S; Ogawa M
Transplantation; 2000 Nov; 70(9):1363-71. PubMed ID: 11087154
[TBL] [Abstract][Full Text] [Related]
56. The role of major and minor histocompatibility antigens in active enhancement of rat kidney allograft survival by blood transfusion.
Hutchinson IV; Morris PJ
Transplantation; 1986 Feb; 41(2):166-70. PubMed ID: 3511578
[TBL] [Abstract][Full Text] [Related]
57. Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy?
Kitade H; Kawai M; Koshiba T; Giulietti A; Overbergh L; Rutgeerts O; Valckx D; Waer M; Mathieu C; Pirenne J
Transplantation; 2004 Dec; 78(12):1747-55. PubMed ID: 15614147
[TBL] [Abstract][Full Text] [Related]
58. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
59. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
